APXTW vs BIO
Apex Treasury Corporation (APXTW) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Apex Treasury Corporation (APXTW) common stock listed on NASDAQ.
BIO (BIO) common stock.
APXTW does not have a complete income-statement cache yet.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
APXTW currently screens at market cap $0. BIO currently screens at market cap $0.
Not investment advice. Open the APXTW and BIO stock pages for the full models.
Not investment advice.